Gimatecan in Treating Patients With Recurrent or Progressive Primary Malignant Glioma

Summary

RATIONALE: Drugs used in chemotherapy, such as gimatecan, work in different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: This phase I/II trial is studying the side effects and best dose of gimatecan in treating patients with recurrent or progressive primary malignant glioma.

Timeline

Start

2004-05

Primary completion

—

Completion

2005-06

Drugs

Indications